PriceSensitive

Kovo HealthTech (TSXV:KOVO) signs IP licensing partnership

Health Care, Market News
TSXV:KOVO
21 November 2022 09:00 (EDT)

Source: Kovo HealthTech

Kovo HealthTech Corporation (KOVO) has signed a two-year perpetual IP license with a long-term client valued at US$750,000.

Kovo CEO Greg Noble commented on the news.

“Leveraging our IP investment has been a strong strategic focus in 2022, and we’re pleased to confirm that Kovo has signed a two-year deal with one of our long-term partners who operates an 18-bed private clinic in the Cayman Islands. The contract is already in effect, and our team is in the process of customizing and extending our IP in partnership with the facility,” he says, adding that the contract took effect on November 1, 2022, and is valued at $750,000 over two years.

In its last quarter, Kovo posted 211% year-over-year revenue growth driven by a combination of organic growth of its core SaaS-style medical billing software and services business — and two strategic and accretive acquisitions the company completed in 2021.

Kovo HealthTech Corporation is a healthcare technology company that specializes in Billing-as-a-Service, offering SaaS-style recurring revenue contracts and software for more than 1700 US healthcare providers. Kovo helps healthcare providers track and manage complex patient care registration, services, billing and payments using its OneRev technology platform. Kovo currently processes over C$250 million in annual billing transactions for more than 3.5 million patients.

Kovo HealthTech Corporation (KOVO) opened trading at C$0.08.


Related News